Suppr超能文献

肝脏及肝外组织中肝脂肪酶的合成。

Synthesis of hepatic lipase in liver and extrahepatic tissues.

作者信息

Doolittle M H, Wong H, Davis R C, Schotz M C

机构信息

Laboratory of Lipid Research, Veterans Administration, Wadsworth Medical Center, Los Angeles, CA 90073.

出版信息

J Lipid Res. 1987 Nov;28(11):1326-34.

PMID:3323389
Abstract

Immunoprecipitations of hepatic lipase from pulse-labeled rat liver have demonstrated that hepatic lipase is synthesized in two distinct molecular weight forms, HL-I (Mr = 51,000) and HL-II (Mr = 53,000). Both forms are immunologically related to purified hepatic lipase, but not to lipoprotein lipase. HL-I and HL-II are also kinetically related and represent different stages of intracellular processing. Glycosidase experiments suggest that HL-I is the high mannose microsomal form of the mature, sialylated HL-II enzyme. Hepatic lipase activity was detected in liver and adrenal gland but was absent in brain, heart, kidney, testes, small intestine, lung, and spleen. The adrenal and liver lipase activities were inhibited in a similar dose-dependent manner by hepatic lipase antiserum. Immunoblot analysis of partially purified adrenal lipase showed an immunoreactive band co-migrating with HL-II at 53,000 daltons which was absent in a control blot treated with preimmune serum. Adrenal lipase and authentic hepatic lipase yielded similar peptide maps, confirming the presence of the lipase in adrenal gland. However, incorporation of L-[35S]methionine into immunoprecipitable hepatic lipase was not detected in this tissue. In addition, Northern blot analysis showed the presence of hepatic lipase mRNA in liver but not adrenal gland. The presence of hepatic lipase in adrenal gland in the absence of detectable synthesis or messenger suggests that hepatic lipase originates in liver and is transported to this extrahepatic site.

摘要

对脉冲标记的大鼠肝脏中的肝脂肪酶进行免疫沉淀分析表明,肝脂肪酶以两种不同分子量的形式合成,即HL-I(分子量51,000)和HL-II(分子量53,000)。这两种形式在免疫学上均与纯化的肝脂肪酶相关,但与脂蛋白脂肪酶无关。HL-I和HL-II在动力学上也相关,代表细胞内加工的不同阶段。糖苷酶实验表明,HL-I是成熟的、唾液酸化的HL-II酶的高甘露糖微粒体形式。在肝脏和肾上腺中检测到肝脂肪酶活性,但在脑、心脏、肾脏、睾丸、小肠、肺和脾脏中未检测到。肝脂肪酶抗血清以类似的剂量依赖性方式抑制肾上腺和肝脏的脂肪酶活性。对部分纯化的肾上腺脂肪酶进行免疫印迹分析显示,在53,000道尔顿处有一条与HL-II共迁移的免疫反应条带,在用免疫前血清处理的对照印迹中不存在该条带。肾上腺脂肪酶和纯肝脂肪酶产生相似的肽图谱,证实肾上腺中存在该脂肪酶。然而,在该组织中未检测到L-[35S]甲硫氨酸掺入可免疫沉淀的肝脂肪酶中。此外,Northern印迹分析显示肝脂肪酶mRNA存在于肝脏中,而不存在于肾上腺中。在肾上腺中存在肝脂肪酶,但未检测到其合成或信使核糖核酸,这表明肝脂肪酶起源于肝脏并转运至这个肝外部位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验